Table 1. Median Survival of Nude Mice Harboring MYCN-Amplified BE(2)-C or Non-amplified SK-N-AS Xenograft Tumors.

	treatment (mice per cohort)	median survival (days)	log-rank test (vs vehicle)	log-rank test (vs perifosine)	log-rank test (vs vincristine)
xenograft model of BE(2)-C	vehicle (n = 8)	18	N/A	0.132	0.541
	perifosine (n = 8) 20 mg/kg per os, 5 days per week	20	0.132	N/A	0.529
	vincristine (n = 8) 0.2 mg/kg i.v., 5 days	20	0.541	0.529	N/A
	vincristine + perisofine (n = 7)	31	0.016	0.039	0.026
xenograft model of SK-N-AS	vehicle (n = 8)	21	N/A	0.33	0.369
	perifosine (n = 8) 15 mg/kg per os, 5 days per week	19	0.33	N/A	0.455
	vincristine (n = 8) 0.2 mg/kg i.v., 5 days	26	0.369	0.455	N/A
	vincristine + perisofine (n = 8)	28	0.008	0.003	0.063